ADAPTIVE BIOTECHNOLOGIES COR (ADPT) — Hedge Fund Ownership Q1 2026
ADPT
- ADAPTIVE BIOTECHNOLOGIES COR (ADPT) is held by 2 of 84 tracked hedge funds, with Viking Global Investors (1%) and Polen Capital Management (0%) holding the largest stakes, indicating limited hedge fund interest relative to peers.
- The biggest decreases in ADPT holdings came from Polen Capital Management (-64%), suggesting profit-taking or de-risking.
- Overall, hedge funds decreased exposure to ADAPTIVE BIOTECHNOLOGIES COR (ADPT) by -1% vs the prior quarter and +0% vs prior year.
| # | Fund | % of Portfolio † | Shares † | Shares vs Prior Quarter † | Shares vs Prior Year † | Aggregate Value † | Reported Price * | Option |
|---|---|---|---|---|---|---|---|---|
| 1 |
Viking Global Investors Andreas Halvorsen
|
1.16% | 30.0M | — | — | $416.3M | $13.88 | — |
| 2 |
Polen Capital Management
|
0.01% | 116K | -64.38% | — | $1.6M | $13.88 | — |
| 2 | Total | — | 30.1M | -0.69% | +0.00% | $417.9M | — | — |
* Reported price is not an actual purchase or sale price. It is the price as of the last portfolio date.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.